Health News

Breast Cancer: Knowing Your Options
Some women with breast cancer may not feel completely informed about their treatment options, according to a new study.
A Look at Women's Breast Cancer Treatment Decisions
Many women with early-stage breast cancer may consider aggressive treatment choices, a new study found.
The Test That Could Save Women's Lives
Many women who had a raised risk of breast and ovarian cancer were not being tested for a gene that signifies a much higher cancer risk, a new study found.
The Problem with False Positives
Women who receive a false positive result on a mammogram screening may be more likely to skip or delay their next screening, according to a new study. And that could put their health at risk.
Men and HPV Vaccination
Despite human papillomavirus (HPV) vaccination programs becoming available to the public in 2009, vaccination rates among men remained relatively low, a new study found.
In Vitro and Breast Cancer Risk
In vitro fertilization (IVF) treatments were not tied to an increased risk of breast cancer, a new study found.
Women with AFib May Face Another Risk
A 20-year study of nearly 35,000 women found that those who were diagnosed with atrial fibrillation (AFib) may have a raised risk of cancer.
Why Are More Women Having Mastectomies?
In 2013, actress Angelina Jolie elected to undergo a double mastectomy after testing positive for the BRCA1 gene mutation. This mutation greatly increases the risk for breast cancer. The star encouraged other women to get tested for BRCA1, and it appears many did.
FDA Expands Indication For Breast Cancer Rx
On February 19, 2016, the U. S. Food and Drug Administration approved palbociclib (IBRANCE Capsules, Pfizer, Inc.) in combination with fulvestrant for the treatment of women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer with disease progression following endocrine therapy.
The Effect of BRCA Testing on Breast Cancer Treatment
Genetic testing in younger women with breast cancer may be getting more common. And that could have an effect on those women's future treatment decisions.